Clinical Trials Browser

Phase 2/3 × Standard of Care × Gastrointestinal × Clear all

NCT07241715 2025-11-21

CONVERGENCE

Phase 2/3 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT05833815 2024-08-13

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Phase 2/3 Recruiting

Gastrointestinal

Gallbladder Neoplasms

NCT01655641 2012-10-16

TMGS

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms